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First Quarterly Report
In the period between October 1st, 19^2 and January 1st, 1953*
six experiments have been performed. These were given serial numbers
1-6, preceded by "CD" (Camp Detrick), as well as numbers in the
series of experiments that have been performed in this laboratory,
preceded by C,S,H, (Cold Spring Harbor),
In all these experiments the mice were young males from strain
C58, with a pedigree of over 9^ generations of brother by sister
matings. The transplanted leukemia has been line I^, or its sub-
branch I^a^ number following this designation indicates the
number of successive C58 hosts in which this population of leukemic
cells has been grown since its origin from a case of spontaneous
lymphatic leukemia that developed under natural conditions in 1929*
The degree of induced resistance that can be detected is
limited by the size of the challenging dose: the smaller the dose
that will kill all the controls, the weaker the resistance
detectable,
The primary criterion of resistance is indefinite survival
after all the controls have died, A second criterion of resistance
is the lengthening of the interval before death as compared with
the controls. Thus the greatest possible uniformity of all the
mice in an experiment has basic importance. In all experiments,
equal numbers of treated and control mice have been used and in the
groups to be compared critically each litter is equally represented^
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CDl and CD2.
Vifill 0,3% polyethylene glycol In the 0,9% saline which is
routinely used as suspending medium for the leukemia cells from
minced spleens, reduce the variability in the interval before death
of the inoculated host and eliminate occasional survivors from very
-fl
dilute (ij." X standard) doses?
These two experiments, covering doses of I4. if , if ^ and if
X "standard" show a slight hastening of death and a possible slight
increase in spleen size in the glycol groups as compared with their
saline controls# But with the highest dilution of the dose the
occasional survivor is not eliminated. The use of glycol does not
offer enough practical advantage to justify its routine use,
CD3.
Will a resistant state be induced by treatment with whole dog's
blood 1-3 days before challenge with line leukemia? This question
was raised by the various parallels between the resistance success
fully induced by certain procedures against line leukemia and
Dr. Victor's studies on inducing resistance, A single treatment
with fresh tissue from a mouse strain unrelated to the strain of
susceptible hosts enables the mouse to survive a dose of leukemic
cells 100^ lethal to the untreated controls. Would tissue (blood)
from a different order of mammals (instead of a different strain
of the same species) induce a similar phenomenon? The results give
no evidence of any delay in death resulting from the treatment with
dog blood, whether this was given one, two, or three days before
the challenge dose. Indeed one mouse in each of the treated groups
died before the first control.
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CDli.
To eliminate possible effects of freezing upon the dog blood,
an experiment was performed with dog blood drawn immediately before
treating the mice. In this case the challenging dose of leukemic
Q
cells was reduced to Ij." x standard, and given one and two days
after the treatment.
These modifications (the elimination of freezing and a reduc
tion of the challenging dose to I/16) did not change the result.
Although two delayed deaths appeared in group A (treatment 1^8 hours
before challenge) two negatives occurred in the controls from the
same litters and another control death was equally delayed.
CD5.
The leukemic cells of line themselves produce a substance
that directly and rapidly induces resistance in the host. This has
been demonstrated by treatment with leukemic cells after moderate
heating, or disruption by sonic vibration.
This experiment attempted to determine whether protective
action could be found in the suspending medium after the leukemic
cells had been gently agitated. The results were inconclusive, in
that after centrifugation at 2000 x G for 30 minutes enough leukemic
cells remained in the supernatant to significantly shorten the
Interval before death as compared with the controls, when challenged
in two days with a highly dilute dose, Tn spite of this, three of
25 mice treated with the supernatant survived and none of the 25
controls. Considering this experiment by itself these survivors
might seem significant, but in other experiments controls have
survived this same dilute dose (Ij."®), as in Exp, CDlp,
cd6.
The resistance induced by heated line cells may resist a
highly dilute dose of unheated leukemic cells given at once; after
i;.8 hours the resistance is considerably stronger, but then soon
weakens. After 8 days survival is very doubtful. This stands
in contrast to the persistence of resistance developed after a very
few untreated leukemic cells have been resisted and raises the
question whether the mechanism in the two cases is different or
whether the difference depends the amovint of protective material
available in the heated cells, compared with unheated cells.
Although vastly more heated cells are inoculated, they do not
multiply, whereas the unheated cells' do multiply and establish
histologically demonstrable lesions before succumbing to the
resistance mechanism. This experiment attempted to increase the
amount of protective material by repeated doses of heated cells.
Groups of litter-mate hosts were given 1, 2, and 3 daily treatments
with line cells heated for lii minutes in a [|.6o C water bath and
challenged 9 days after the last treatment with a dose that
previously had been resisted at 8 days after treatment with heated
cells by only 3 out of 20 mice.
In the present experiment only one mouse died of the 10
receiving three treatments of heated cells but the single treatment
groups gave unexpectedly high survival--? out of 10, Five controls
on the first of the three treatments were challenged (ii." ) in 2 days
and all survived, while all the 5 controls on the challenging dose
died from this particular suspension of unheated cells.
Evidently 9 days was too soon to test the differences between
the persistence of 1 vs, 3 treatments with heated cells.
Protocols for each experiment follow.
Experiment GDI CSH 2120 2068 10/9/52 -5-
Gomparison of 0,3^ polyethylene glycol (abbreviated = "glyc")
in 0.9^ saline with 0»9^ saline as suspending medium for high
dilutions of line leukemia.
Donor spleen (^[|.l682, GSH 2113, 1^ 2067) was cut into two parts,
each part weighed and minced separately and suspended with the
respective solutions; 2,3 cc per gram of spleen = "standard suspen-,
sion," Each standard suspension at once reduced to and for
each subsequent dilution the saline control was diluted immediately
after the "glyc" suspension. All suspensions originally refrigerated
and maintained cold in crushed ice.
Dilution schedule
Standard - 1 g, spleen to 2,3 oc, suspending medium
i^'"3 = ,05 cc std + 3»15 cc "glyc" or saline
= ,20 cc + 3,00 cc " " "inoculate 5 mice;each medium
= ,10 cc + 6,30 cc " " " " m " " "It It
= ,10 cc ij."® + 6.30 cc u  n 10
Mice Strain C58, males, born 8/17-8/23, 1952; equal number from each
litter in "glyc" and saline groups.
Saline controls inoculated immediately after "glyc" group with same
dilution.
All inoculations between 12M and 12:50 P.M.
Results : Intervals before death by I/I4. days
7th
Dilution
"Glyc" 1 3
Saline 211
Dilution Iq"®
"Glyc"
Saline
Dilution
"Glyc"
Saline
8th 9th 10th j 11th 12th 13th .15th
1
1
6
2 111
6 1
1 5
1 neg,
2  1
1 neg.
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Spleen size (cm.) averages
Dilution Length Width
[^-5 "glyc" 2.88 .814.
saline 2.98 .80
i|.-8 "glyc" 3.06 .93
saline 2.90 .91
^-11 Mglyc" 2.92 .93
saline 2.71 *85
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Exp. CD2 CSH 212i^. 2069. 10/l6/52
Further test of Q,2>% polyethylene glycol as suspending
medium using dilution this being the dilution to be used
chiefly in subsequent experiments.
Procedure as in GDI.
Two parts of saxiie leukemic spleen (Donor fi^-lBig from CSH 2119
2068) separately weighed, minced and suspended in respective
solutions. All vials kept in crushed ice.
Dilution schedule.
Standard = (1 g, spleen to 2.3 cc. suspending medium)
= ,0^ cc Standard + 3«l5 cc, medium
= ,0^ cc + 3.15 cc. suspending mediiin inoculated .2 cc.
per mouse; 10 mice each medium.
Results: Interval before death by l/i;. days
Dilution [|.-6
"giyc"
saline
8th , 9th
1+15
2 2 §
Spleen size in cm. averages
Length Width
"glyc"
saline
3.03
3.01
.91+
.92
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Experiment CD3 CSH 2130 2070 10/23/52
Treatment with frozen, fresh, heparinized dog blood (whole)
,i|. CO per mouse, 1 or 2 or 3 days before challenging with line
leukemia--dose x standard.
Each litter (strain C58 cfs born 8/31-9/13/1952) divided
equally between four groups = i.e. challenged after 1 day, 2 days,
3 days and untreated controls.
Dilution schedule.
Spleen from -^1^2062 in CSH 212i|.. 1^^ 2069, dose x Standard on
10/16/52
Standard = 2,3 cc. saline to 1 g. spleen weight.
= .05 CO Std, + 3.15 saline
= ,15 cc + 9-^5 cc. saline inoculated i^.0 mice; 0.2 cc
per mouse
Order of inoculation (5 mice per box)
1st box of each of the four groups, then 2nd box of each
group. All inoculations within 20 minutes (I4.: 30-1^:50 P.M.).
Results;
Time of death by l/i|. days
Days between
treatment and
challenge
3
2
1
Untreated controls
7th
•  • •
8th
«  • •
3 hr
331
331
k 1
9th
(1'"* negative)
(1 killed by accident)
I
1  1
Reinoculated 11/6/52 (i|-~^) died in 8 d, showing record of
1st inoculation probably in error--possibly into bladder.
Survival of one lethal dose ensures survival of a second one.
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Spleen size (cm.) averages
Length Width Range of lengths
3 days . 2,98 *98 2,8-3«l
2  " 2.92 .90 2.8 - 3.2
1 day 2.88 .99 2.8-3*2
Controls 2,90 .9^ 2.7 - 3*2
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Experiment CDif GSH 2ll).2 2073 11/13/52
Treatment with heparinized dog blood, immediately after
withdrawal from dog, ,1^ cc. per mouse, 2l\. hours (11/12/52)
and i^.8 hours (ll/ll/52) before challenging with If'®
X Standard. Each litter of C58 equally represented in each
of these two treated groups and the untreated controls, i.e.,
if sets of 3 boxes each. Each group included if boxes of five
mice.
Inoculation order; 1st box of each group; 2nd box of each
group, etc.
A = treated if8 hrs. before challenge; B - treated 2if hrs.
before challenge; C = controls.
Dilution schedule.
Spleen from cfi|-270if from CSH 2139 lb 2072 ll/6/52--dose
If" X standard. All vials kept in crushed ice; saline pre-
cooled.
Standard - by measurement table.
«»Pif" = .10 cc Std. + 1.5 cc saline
if"^ = ,05 cc if~^ + 3.15 cc saline
if"® = .1$ cc if~^ + 9.if5 cc saline - inoculate first 2 boxes of
each group
if"® = .15 cc if~^ + 9.45 cc saline - inoculate second 2 boxes of
each group
All mice inoculated between 11:12-11:52 A.M.
CDi4- - Distribution of deaths after lb on 11/13/52
V
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Sox
lA
IB
9 th 10th 11th 12th
IC control
2A
23
2C control
3A
3B
3C control
iiA
i+B
i^.C control
1 3
3 11
1 3
2 11
2 11
12 2
2 12
1 3
112
1 2
2 1
1 1
1
1
1 1
1
1 1
2 survivors
Totals
A
B
C controls
6 7 3
1 8 3
4 7
1 1
2 2
1 1
■(s survivors)
Distribution of Spleen Length
Spleen
2.- 3«- cm Length Width
.6 .7 .8 .9 .0 .1 .2 .3 .i|. .5 .6 Averages (cm)
A 1 ""'l 1 k 3 6 1+ 3.19 .97
B 1 k 5 5 2  2 1 3.26 .98
C  1
controls
1  2 2 3 5 2 1  1 3.09 .95
Delayed deaths
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CD$ CSH 211^-9 Iba 207l|. 11/20/^2, and CSH 21^2 2075, 11/27/52
Treatment with supernatant from line diluted to
X standard after agitation for 30 minutes on mechanical shaker and
centrifugation 2000 x 0 for 30 minutes; challenged in two days with
a dose i|.~Q x standard. 5 boxes of ^  treated mice compared with
5 boxes of litter-mate controls.
Time of death by l/l| days
Average
7th 8th 9th 10th spleen
;  Length Width
11/20 Supernatant
Controls
11/27 Supernatant
Controls
11/27 Supernatant
Controls
11/27 Supernatant
Controls
11/27 Supernatant
Controls
(1 survived) 2.92
2 2 1
Totals
1 2
1112
1 2
112 1
1 2
1 2
111
(3 surv.)
1  2
2.98 .88
2.8ii
2.82 .8ii
2.86 .80
.85
2.98 .90
2.95 .85
2.98 .90
2.72 .90
3.00 .90
2.87 . 86
2.93 .88
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CD6 CSH 2163 2079: Heat series 128,
Line 2076 - Spleens from CSH 2156, heated 1^.6° 0, li|. minutes
,25 cc, of standard suspension in saline, given on 1 or 2 or 3
successive days,
L
Challenged (I)." ) on 9th day after the last heated cells.
Each litter (males only) equally represented in each of the
three treatment-groups and the group of untreated controls.
Results given by litters.
Intervals before death--days
Controls on
Mothers
dose
Al Bl ^1 ^1
l4-Olil5 Surv, Surv, Surv, 8-
kll\.02 Surv, ID 8+ 8 1/2
1^1571 Surv, Surv, Surv, 8+
ifl668 Surv, Surv, Surv, 8+
i^.1129 Surv, Surv, 8- 8
A2
^2
l|0i^90 Surv, 13 Surv. 8-
39668
0
<
•
CD 
+ 1
8
Surv,
 1100
ij.1209 Surv, 10- Surv, 8-
ifll85 Surv. Surv, Surv, 8-
Total deaths 1/10 5/10 3/10 10/10
Survival 90?^ 50% 70% 0%
